OGN, osteoglycin, 4969

N. diseases: 55; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.010 AlteredExpression disease BEFREE In multivariate analysis, osteoglycin levels were an independent factor for complex lesion but not for CAD. 29503411 2018
CUI: C2350875
Disease: Constrictive Bronchiolitis
Constrictive Bronchiolitis
0.010 Biomarker disease BEFREE Constrictive Bronchiolitis (CB) has been reported in US Operation Iraqi Freedom/Enduring Freedom (OIF/OEF) deployers but not in those from prior US conflicts. 30117179 2018
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 AlteredExpression group BEFREE OGN mRNA expression was dramatically increased in meningiomas compared to a spectrum of other brain tumors and normal brain. 28923059 2017
CUI: C0025286
Disease: Meningioma
Meningioma
0.010 Biomarker disease BEFREE OGN-overexpressing meningioma cells demonstrated an elevated rate of cell proliferation, cell cycle activation, and colony formation as compared with cells transfected with control vector. 28923059 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.010 Biomarker disease BEFREE OGN may plays a significant role in osteoporosis, which may also provide a potential target for therapeutic intervention of senile osteoporosis characterized by altered differentiation of BMSCs into osteoblasts and adipocytes. 29073887 2017
CUI: C0029459
Disease: Osteoporosis, Senile
Osteoporosis, Senile
0.010 Biomarker disease BEFREE Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs. 29073887 2017
CUI: C0237123
Disease: Alcohol or Other Drugs use
Alcohol or Other Drugs use
0.010 Biomarker disease BEFREE These results demonstrate the promise of a web-based, self-management intervention for difficult-to-engage OEF/OIF veterans with behavioral health and substance use concerns. 28270335 2017
CUI: C0276138
Disease: Viral myocarditis
Viral myocarditis
0.010 GeneticVariation disease BEFREE This study uncovered a previously unidentified 72-kDa variant of OGN that is predominant in cardiac human and mouse samples of viral myocarditis. 27878326 2017
CUI: C0278877
Disease: Adult Meningioma
Adult Meningioma
0.010 Biomarker disease BEFREE OGN-overexpressing meningioma cells demonstrated an elevated rate of cell proliferation, cell cycle activation, and colony formation as compared with cells transfected with control vector. 28923059 2017
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.010 Biomarker group BEFREE Our results indicate that serum osteoglycin is a potential predictor of adverse outcomes in patients with CKD. 28824047 2017
Meningioma, benign, no ICD-O subtype
0.010 Biomarker disease BEFREE OGN-overexpressing meningioma cells demonstrated an elevated rate of cell proliferation, cell cycle activation, and colony formation as compared with cells transfected with control vector. 28923059 2017
CUI: C2945695
Disease: Limb ischemia
Limb ischemia
0.010 AlteredExpression disease BEFREE The expression of OGN was decreased in a limb ischaemia mouse model. 28069703 2017
CUI: C0003123
Disease: Anorexia
Anorexia
0.010 Biomarker disease BEFREE Notably, mimecan-MBP also induced anorexia in A(y)/a and db/db mice. 26870797 2015
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 Biomarker disease BEFREE In human heart failure, osteoglycin is a promising biomarker for ischemic heart failure. 25520363 2015
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE In human heart failure, osteoglycin is a promising biomarker for ischemic heart failure. 25520363 2015
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 AlteredExpression disease BEFREE Adenoviral overexpression of osteoglycin in wild-type mice significantly improved collagen quality, thereby blunting cardiac dilatation and dysfunction after MI. 25520363 2015
CUI: C0264732
Disease: Cardiac dilatation
Cardiac dilatation
0.010 AlteredExpression disease BEFREE Adenoviral overexpression of osteoglycin in wild-type mice significantly improved collagen quality, thereby blunting cardiac dilatation and dysfunction after MI. 25520363 2015
CUI: C0206682
Disease: Follicular thyroid carcinoma
Follicular thyroid carcinoma
0.010 AlteredExpression disease BEFREE Four proteins showed significant differences between FA and FTC (peroxisomal proliferator-activated receptor-γ, serum deprivation response protein, osteoglycin, and dipeptidase 1). 23751876 2013
CUI: C0279671
Disease: Cervical Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma
0.010 AlteredExpression disease BEFREE A differential protein pattern for SCC was, e.g. over-expressed (OE) eukaryotic translation initiation factor 3-2β, neutrophil cytosolic factor 2, annexin A6 (ANXA6), for SVC it was OE cathepsin D, γ-catenin, RAB2A, for both cancers it was OE apolipoprotein E, tropomyosin 3, HSPA8, and underexpressed cytokeratin 13, osteoglycin. 21137014 2010
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.010 Biomarker disease BEFREE This is the first study showing that mimecan could serve as an excellent pathological biomarker to distinguish NSCLCs from SCLCs. 19787221 2009
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 Biomarker disease BEFREE Therefore, we hypothesize that mimecan could serve as a biomarker for differentiating various histological types of lung cancers. 19787221 2009
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.010 Biomarker group BEFREE Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis. 18443592 2008
CUI: C0001430
Disease: Adenoma
Adenoma
0.010 AlteredExpression group LHGDN All adenoma and cancer tissues did not express mimecan, but all normal mucosa did (P < 0.01). 17895523 2007
CUI: C0017601
Disease: Glaucoma
Glaucoma
0.010 Biomarker disease BEFREE Mimecan and activinA, which have been shown to be upregulated in models of glaucoma, were both found to be elevated in POAG TM. 16565384 2006
CUI: C0339573
Disease: Glaucoma, Primary Open Angle
Glaucoma, Primary Open Angle
0.010 AlteredExpression disease BEFREE Mimecan and activinA, which have been shown to be upregulated in models of glaucoma, were both found to be elevated in POAG TM. 16565384 2006